Tryp Therapeutics Inc. carries a market capitalization of 5.42M, placing it among publicly traded companies globally.
| Market Cap | 5.42M |
| Enterprise Value | N/A |
Tryp Therapeutics Inc.'s stock has declined approximately -4.74576% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.04.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.74576% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.04 |
| Average Volume (20 Days) | N/A |